Ligand Pharmaceuticals: Q2 Earnings Insights

Ligand Pharmaceuticals (NASDAQ:LGND) reported its Q2 earnings results on Monday, August 8, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

Ligand Pharmaceuticals reported an EPS of $1.03.

Revenue was down $27.26 million from the same period last year.

Last quarter the company beat on EPS by $0.1 which was followed by a 5.54% drop in the share price the next day.

Here's a look at Ligand Pharmaceuticals's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	0.66	1.37	1.04	1.34
EPS Actual	0.76	1.80	1.58	1.63
Revenue Estimate	34.21M	65.32M	55.65M	70.41M
Revenue Actual	45.69M	72.47M	64.83M	84.67M

To track all earnings releases for Ligand Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Benzinga